---
title: "Raltegravir in Intro to Pharmacology"
description: "Raltegravir is an HIV integrase inhibitor that blocks viral DNA integration into host cells, lowering viral load and fitting into antiretroviral therapy."
canonical: "https://fiveable.me/introduction-to-pharmacology/key-terms/raltegravir"
type: "key-term"
subject: "Intro to Pharmacology"
unit: "Unit 10"
---

# Raltegravir in Intro to Pharmacology

## Definition

Raltegravir is an antiretroviral drug used in Intro to Pharmacology to show how integrase inhibitors stop HIV from inserting its DNA into the host genome. It is usually given with other HIV medicines.

## What It Is

Raltegravir is an antiretroviral drug in the integrase inhibitor class, used to treat HIV in Intro to Pharmacology when you are studying how drugs block a virus at a specific step in its life cycle. Its main job is to stop the HIV integrase enzyme from inserting viral DNA into the host cell genome. Without that integration step, HIV cannot keep using the infected cell to make more virus as efficiently.

That mechanism is different from drugs that block entry, reverse transcription, or protease action. Raltegravir targets what happens after HIV has already entered the cell and after its RNA has been copied into DNA. That makes it a good example of how modern antiviral therapy can be very precise, aiming at one viral enzyme instead of broadly suppressing the whole immune system.

In a pharmacology class, you usually meet raltegravir as part of combination antiretroviral therapy, not as a stand-alone cure. HIV mutates quickly, so using one drug by itself can let resistant virus emerge. Pairing raltegravir with other antiretrovirals lowers the chance of resistance and helps drive viral load down more effectively.

A useful way to think about it is as a “lockout” at the integration stage. The virus can still attach, enter, and begin copying its genetic material, but it gets stuck before it can permanently set up shop in the host cell DNA. That is why the drug is so useful for lowering active replication, improving immune function, and keeping infection under better control.

Students often remember raltegravir as one of the first integrase inhibitors, which matters because it marked a newer strategy in HIV treatment. Instead of only targeting older steps like reverse transcriptase or protease, it showed that blocking integration could be an effective and well-tolerated option in real patients.

## Why It Matters

Raltegravir matters because it gives you a clean example of targeted antiviral action. In Intro to Pharmacology, that means you are not just memorizing a drug name, you are learning how a specific enzyme inhibitor changes the viral replication cycle and why that changes treatment choices.

It also helps you compare drug classes. If you can explain why raltegravir is an integrase inhibitor, you can more easily separate it from nucleoside analogs, protease inhibitors, and viral entry inhibition. That kind of comparison shows up when you are asked to sort medications by mechanism rather than by disease name.

Raltegravir is also useful for understanding combination therapy in HIV. One drug rarely controls HIV well enough on its own, so you have to think about resistance, viral load, and how different agents work together. A case question might describe a patient starting ART and ask why multiple drugs are prescribed, and raltegravir fits that logic perfectly.

It is one of those terms that connects mechanism to clinical effect. Blocking integration leads to less productive infection, which leads to lower viral load, which can support better immune recovery over time.

## Connections

### Integrase Inhibitors

Raltegravir belongs to this class, so this is the category you use when you want the bigger mechanism. If a question asks how the drug works, the answer is not just the brand name, it is that it blocks HIV integrase and prevents viral DNA from joining the host genome. That class distinction is often the fastest way to identify the drug on a quiz.

### Antiretroviral Therapy (ART)

Raltegravir is usually part of ART, not the whole treatment plan by itself. ART combines multiple drugs that attack HIV at different stages, which makes resistance less likely and suppression more effective. If you are reading a case, seeing raltegravir often tells you the patient is being managed with a multi-drug HIV regimen.

### Viral Load

Viral load is one of the main outcomes you track when a patient takes raltegravir. As the drug blocks integration, fewer infected cells keep producing virus, so the amount of virus in blood can fall. In problem sets or case studies, a falling viral load is usually the sign that the regimen is working.

### [Protease Inhibitors](/introduction-to-pharmacology/key-terms/protease-inhibitors)

These are often compared with raltegravir because they treat HIV too, but they act at a different step. Protease inhibitors stop new viral proteins from being cut into functional pieces, while raltegravir stops the viral DNA from integrating into the host genome. If you mix them up, the best fix is to trace the life-cycle stage each one blocks.

## On the AP Exam

A quiz item or case analysis may ask you to identify raltegravir from its mechanism, so look for clues like “blocks HIV integrase” or “prevents viral DNA integration.” You may also be asked to place it in the HIV replication cycle, which means naming the step after reverse transcription and before long-term viral persistence in the host genome.

In a short-answer question, the strongest response links mechanism to outcome: raltegravir inhibits integration, which helps reduce viral replication and viral load when used with other antiretrovirals. If a patient scenario mentions combination HIV therapy, resistance concerns, or a newer class of antiviral drugs, raltegravir is a likely answer choice.

For comparison questions, be ready to separate it from drugs that block entry, reverse transcription, or protease processing. The safest move is to state the exact stage it targets and then explain what that does to HIV replication.

## raltegravir vs Protease Inhibitors

These are easy to mix up because both are HIV drugs used in combination therapy, but they act at different points. Raltegravir blocks integration of viral DNA into the host genome, while protease inhibitors stop viral proteins from being processed into mature, functional proteins. If the question is about inserting DNA, think raltegravir; if it is about viral protein maturation, think protease inhibitors.

## Key Takeaways

- Raltegravir is an HIV integrase inhibitor, so it blocks the viral DNA from integrating into the host cell genome.
- It is usually used as part of antiretroviral therapy, because HIV treatment works better when multiple stages of the virus life cycle are targeted.
- A drop in viral load is one of the main signs that the drug regimen is doing what it should.
- This drug is a good example of a newer antiviral strategy that targets a precise viral enzyme instead of attacking the virus more broadly.
- If you can place raltegravir in the HIV replication cycle, you can usually answer the test question correctly.

## FAQs

### What is raltegravir in Intro to Pharmacology?

Raltegravir is an antiretroviral drug that treats HIV by inhibiting the integrase enzyme. That keeps viral DNA from integrating into the host genome, which slows down viral replication. In pharmacology, it is a classic example of an integrase inhibitor.

### How does raltegravir work?

It binds to and inhibits HIV integrase, the enzyme the virus uses to insert its DNA into the host cell’s DNA. Without that integration step, the virus cannot fully establish infection in the same way. This is why raltegravir is effective as part of combination HIV therapy.

### Is raltegravir a protease inhibitor?

No, raltegravir is not a protease inhibitor. It is an integrase inhibitor, so it acts earlier in the HIV life cycle by preventing viral DNA integration. Protease inhibitors work later, during viral protein processing and maturation.

### Why is raltegravir used with other HIV drugs?

HIV mutates quickly, so using one drug alone can lead to resistance. Raltegravir is typically combined with other antiretrovirals to attack the virus at multiple stages and keep viral load lower. That combination approach is a big theme in HIV pharmacology.

## Related Study Guides

- [10.3 Antiviral drugs](/introduction-to-pharmacology/unit-10/antiviral-drugs/study-guide/wPEj02CSXbbS1SUV)

## About This Document

Canonical Fiveable pages are available as Markdown at the same path plus `.md`.

- [llms.txt](https://fiveable.me/llms.txt): index of Fiveable's sections and URL patterns
- [llms-full.txt](https://fiveable.me/llms-full.txt): complete subject and unit listing
- [MCP server](https://fiveable.me/mcp): call Fiveable as tools instead of fetching pages (`https://fiveable.me/api/mcp`)
- [MCP server for AP teachers](https://fiveable.me/mcp/teachers): a teacher's classes, assignments and AP-rubric grading (`https://fiveable.me/api/mcp/teacher`)

## Structured Data

```json
{"@context":"https://schema.org","@graph":[{"@type":"LearningResource","@id":"https://fiveable.me/introduction-to-pharmacology/key-terms/raltegravir#resource","name":"Raltegravir in Intro to Pharmacology","url":"https://fiveable.me/introduction-to-pharmacology/key-terms/raltegravir","learningResourceType":"Concept explainer","educationalLevel":"AP® / High School","about":{"@id":"https://fiveable.me/introduction-to-pharmacology/key-terms/raltegravir#term"},"audience":{"@type":"EducationalAudience","educationalRole":"student"},"dateModified":"2026-07-03T02:23:32.792Z","isPartOf":{"@type":"Collection","name":"Intro to Pharmacology Key Terms","url":"https://fiveable.me/introduction-to-pharmacology/key-terms"},"publisher":{"@type":"Organization","name":"Fiveable","url":"https://fiveable.me"}},{"@type":"DefinedTerm","@id":"https://fiveable.me/introduction-to-pharmacology/key-terms/raltegravir#term","name":"raltegravir","description":"Raltegravir is an antiretroviral drug used in Intro to Pharmacology to show how integrase inhibitors stop HIV from inserting its DNA into the host genome. It is usually given with other HIV medicines.","url":"https://fiveable.me/introduction-to-pharmacology/key-terms/raltegravir","inDefinedTermSet":{"@type":"DefinedTermSet","name":"Intro to Pharmacology Key Terms","url":"https://fiveable.me/introduction-to-pharmacology/key-terms"}},{"@type":"FAQPage","mainEntity":[{"@type":"Question","name":"What is raltegravir in Intro to Pharmacology?","acceptedAnswer":{"@type":"Answer","text":"Raltegravir is an antiretroviral drug that treats HIV by inhibiting the integrase enzyme. That keeps viral DNA from integrating into the host genome, which slows down viral replication. In pharmacology, it is a classic example of an integrase inhibitor."}},{"@type":"Question","name":"How does raltegravir work?","acceptedAnswer":{"@type":"Answer","text":"It binds to and inhibits HIV integrase, the enzyme the virus uses to insert its DNA into the host cell’s DNA. Without that integration step, the virus cannot fully establish infection in the same way. This is why raltegravir is effective as part of combination HIV therapy."}},{"@type":"Question","name":"Is raltegravir a protease inhibitor?","acceptedAnswer":{"@type":"Answer","text":"No, raltegravir is not a protease inhibitor. It is an integrase inhibitor, so it acts earlier in the HIV life cycle by preventing viral DNA integration. Protease inhibitors work later, during viral protein processing and maturation."}},{"@type":"Question","name":"Why is raltegravir used with other HIV drugs?","acceptedAnswer":{"@type":"Answer","text":"HIV mutates quickly, so using one drug alone can lead to resistance. Raltegravir is typically combined with other antiretrovirals to attack the virus at multiple stages and keep viral load lower. That combination approach is a big theme in HIV pharmacology."}}]},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Intro to Pharmacology","item":"https://fiveable.me/introduction-to-pharmacology"},{"@type":"ListItem","position":2,"name":"Key Terms","item":"https://fiveable.me/introduction-to-pharmacology/key-terms"},{"@type":"ListItem","position":3,"name":"Unit 10","item":"https://fiveable.me/introduction-to-pharmacology/unit-10"},{"@type":"ListItem","position":4,"name":"raltegravir"}]}]}
```